Ubs Group Ag Akoya Biosciences, Inc. Transaction History

Ubs Group Ag

$452 Billion
Q3 2024

A detailed history of Ubs Group Ag transactions in Akoya Biosciences, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 7,044 shares of AKYA stock, worth $18,737. This represents 0.0% of its overall portfolio holdings.

Number of Shares

7,044

Previous 8,162 13.7%

Holding current value

$18,737

Previous $19,000 -0.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$1.96 - $2.94 $2,191 - $3,286	-1,118 Reduced 13.7%	7,044 $19,000
Q2 2024 Aug 13, 2024	SELL	$1.94 - $4.56 $25,776 - $60,588	-13,287 Reduced 61.95%	8,162 $19,000
Q1 2024 May 13, 2024	SELL	$4.33 - $6.06 $17,094 - $23,924	-3,948 Reduced 15.55%	21,449 $100,000
Q4 2023 Feb 09, 2024	BUY	$3.13 - $5.13 $47,854 - $78,432	15,289 Added 151.26%	25,397 $123,000
Q3 2023 Nov 09, 2023	BUY	$4.24 - $7.44 $2,815 - $4,940	664 Added 7.03%	10,108 $47,000
Q2 2023 Aug 11, 2023	BUY	$5.28 - $8.35 $27,910 - $44,138	5,286 Added 127.13%	9,444 $69,000
Q1 2023 May 12, 2023	BUY	$7.6 - $12.68 $19,205 - $32,042	2,527 Added 154.94%	4,158 $34,000
Q4 2022 Feb 08, 2023	BUY	$8.6 - $14.1 $14,026 - $22,997	1,631 New	1,631 $15,000
Q2 2022 Aug 10, 2022	SELL	$8.38 - $12.85 $7,533 - $11,552	-899 Reduced 51.58%	844 $11,000
Q1 2022 May 16, 2022	SELL	$9.84 - $14.97 $8,521 - $12,964	-866 Reduced 33.19%	1,743 $19,000
Q4 2021 Feb 14, 2022	BUY	$11.37 - $15.31 $6,924 - $9,323	609 Added 30.45%	2,609 $40,000
Q3 2021 Nov 15, 2021	BUY	$13.04 - $21.0 $23,172 - $37,317	1,777 Added 796.86%	2,000 $28,000
Q2 2021 Aug 13, 2021	BUY	$17.89 - $26.05 $3,989 - $5,809	223 New	223 $4,000

Others Institutions Holding AKYA

# of Institutions

Shares Held

11.9M

Call Options Held

24.1K

Put Options Held

View Full List

About Akoya Biosciences, Inc.

Ticker AKYA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 37,892,300
Market Cap $101M
Description
Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope...

More about AKYA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account